Cited by 45Heart rate and cardiovascular healthHeart Rate Variability and Autonomic ControlCardiac electrophysiology and arrhythmias

Association of Asymptomatic Bradycardia With Incident Cardiovascular Disease and Mortality: The Multi-Ethnic Study of Atherosclerosis (MESA)

Open access
Dharod, Ajay, Soliman, Elsayed Z., Dawood, Farah, Chen, Haiying, Shea, Steven, Nazarian, Saman, Bertoni, Alain G., for the MESA Investigators·2016·JAMA Internal Medicine

Abstract

IMPORTANCE: Bradycardia has been associated with lower cardiovascular disease (CVD) risk in selected populations. There is a paucity of information available about heart rate (HR) less than 50 beats per minute (bpm) among middle-aged or older adults. OBJECTIVE: To determine whether asymptomatic bradycardia was associated with a lower cardiovascular risk profile, less subclinical atherosclerosis, and decreased incident CVD and mortality. DESIGN, SETTING, AND PARTICIPANTS: This retrospective analysis includes 6733 participants of the Multi-Ethnic Study of Atherosclerosis, which recruited men and women free of clinical cardiovascular disease ages 45 to 84 years from 2000 to 2002 and followed them over 10 years for incident CVD events and mortality. The HR was measured by baseline electrocardiogram. The analysis was performed in June 2014. MAIN OUTCOMES AND MEASURES: The association between HR categories with CVD events and all-cause mortality were examined using Cox proportional hazards models adjusted for potential confounders and mediators. RESULTS: The 6733 participants had a mean (SD) age of 62 (10.2) years; 47% were male. The mean (SD) HR was 63 (9.5) bpm among the 5831 participants not taking an HR-modifying drug; 5.3% had an HR lower than 50 bpm. Preliminary results revealed significant interaction for HR categories according to use of HR-modifying drugs for mortality (P = .002); thus, all further analyses were stratified. An HR of less than 50 bpm was not associated with incident CVD in either subgroup (participants taking or not taking HR-modifying drugs). Among participants not taking HR-modifying drugs, the fully adjusted mortality risk was not different for an HR less than 50 bpm (hazard ratio, 0.71 [95% CI, 0.41-1.09]; P = .12) and increased among those with an HR greater than 80 bpm (hazard ratio, 1.49 [95% CI, 1.08-2.05]; P = .01) (reference HR, 60-69 bpm). Among the 902 participants taking HR-modifying drugs there was an elevated mortality risk associated with an HR less than 50 bpm (hazard ratio, 2.42 [95% CI, 1.39-4.20]; P = .002) and with an HR greater than 80 bpm (hazard ratio, 3.55 [95% CI, 1.65-7.65]; P = .001) (reference HR, 60-69 bpm). CONCLUSIONS AND RELEVANCE: In a contemporary, community-based cohort, bradycardia was generally not associated with incident CVD or mortality except for a potential adverse association between bradycardia among those taking HR-modifying drugs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.7655

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After multivariable risk adjustment, there was no increased risk for incident cardiovascular disease or mortality over a 10 year follow up period in MESA patients with heart rate <50 bpm.

    “After multivariable risk adjustment, there was no increased risk for incident cardiovascular disease or mortality over a 10 year follow up period [9] .”

    From Evaluating and managing bradycardia (2020) · cites this paper as [9]

    The Results report a median follow-up of 10.1 years and no significant increase in adjusted incident CVD risk for participants with heart rates below 50 bpm. The Discussion reports no excess mortality in that heart-rate group among participants not taking heart-rate-modifying drugs, but significantly higher mortality among those taking them. The claim omits that important qualification. (LLM, conf=0.91)

    Experimental — accuracy not yet measured
  • In the MESA study, over 300 patients with a heart rate less than 50 bpm who were not on any heart rate-lowering medication were noted.

    “The Multi-ethnic Study of Atherosclerosis (MESA), a longitudinal study of men and women aged 45-84 years old, noted over 300 patients with a heart rate less than 50 bpm who were not on any heart rate-lowering medication.”

    From Evaluating and managing bradycardia (2020) · cites this paper as [9]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dharod, A., Soliman, E. Z., Dawood, F., Chen, H., Shea, S., Nazarian, S., Bertoni, A. G., & for the MESA Investigators
Affiliations
  • Wake Forest University Health Sciences (US)
  • Columbia University Irving Medical Center (US)
  • Johns Hopkins University (US)
Corresponding author
Dharod, Ajay
Venue
JAMA Internal Medicine
Published
2016-02-01
Volume
176
Issue
2
Pages
219
ISSN
2168-6106 (ISSN-L)
OpenAlex
W2273402626
Cited by
45
References
29
Citations by year
2026: 3 · 2025: 1 · 2024: 16 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2016: 4
FWCI
3.57
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01hc95164-17-0-1, n01hc95165-34-0-1, n01hc95161-24-0-1, n01hc095169-003, n01hc95166-21-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, UL1TR001079, n01hc95163-22-0-1, n01hc95159-40-0-1, UL1TR000040)
  • National Heart, Lung, and Blood Institute (N01 HC-95159, N01-HC-95160, N01 HC-95168, N01 HC95167, (N01-HC-95163, N01 HC-95161, N01 HC95165, N01HC95164, N01‐HC‐95166, N01 HC95169)
  • National Center for Research Resources
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
heart rate, cardiovascular disease incidence, all-cause mortality, subclinical atherosclerosis, carotid intima-media thickness, carotid plaque, middle-aged and older adults, Multi-Ethnic Study of Atherosclerosis, cardiovascular risk, atrial fibrillation, atrial flutter
MeSH terms
Aged, Aged, 80 and over, Bradycardia, Ethnicity, Female, Humans, Male, Middle Aged, Mortality, Retrospective Studies, Risk Factors, United States, Incidence, Atherosclerosis, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review